다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Artelo Biosciences Inc (ARTL)
Artelo Biosciences Inc (ARTL) 뉴스

ARTL

Artelo Biosciences (ARTL)

Artelo Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ARTL

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	22:00	GlobeNewswire Inc.	Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th	NASDAQ:ARTL	Artelo Biosciences Inc
2024/04/23	21:30	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy	NASDAQ:ARTL	Artelo Biosciences Inc
2024/04/22	21:30	GlobeNewswire Inc.	Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time	NASDAQ:ARTL	Artelo Biosciences Inc
2024/03/25	21:00	GlobeNewswire Inc.	Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2024/03/12	22:15	GlobeNewswire Inc.	Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge	NASDAQ:ARTL	Artelo Biosciences Inc
2024/01/23	22:30	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy	NASDAQ:ARTL	Artelo Biosciences Inc
2024/01/08	22:30	GlobeNewswire Inc.	Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12	NASDAQ:ARTL	Artelo Biosciences Inc
2023/12/05	22:30	GlobeNewswire Inc.	Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/30	23:00	GlobeNewswire Inc.	Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/13	22:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/13	22:00	GlobeNewswire Inc.	Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/09	23:00	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/02	21:30	GlobeNewswire Inc.	Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023	NASDAQ:ARTL	Artelo Biosciences Inc
2023/10/04	21:30	GlobeNewswire Inc.	Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia	NASDAQ:ARTL	Artelo Biosciences Inc
2023/09/13	21:30	GlobeNewswire Inc.	Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th	NASDAQ:ARTL	Artelo Biosciences Inc
2023/09/07	21:00	GlobeNewswire Inc.	Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12	NASDAQ:ARTL	Artelo Biosciences Inc
2023/09/06	22:00	GlobeNewswire Inc.	Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12th	NASDAQ:ARTL	Artelo Biosciences Inc
2023/09/05	22:00	GlobeNewswire Inc.	Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th	NASDAQ:ARTL	Artelo Biosciences Inc
2023/08/10	21:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARTL	Artelo Biosciences Inc
2023/08/10	21:00	GlobeNewswire Inc.	Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2023/08/09	05:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARTL	Artelo Biosciences Inc
2023/08/09	05:34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/19	22:00	GlobeNewswire Inc.	Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/17	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/10	21:30	GlobeNewswire Inc.	Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/07	21:23	Edgar (US Regulatory)	Form DEL AM - Delaying amendment	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/07	05:31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/04	03:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/04	03:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARTL	Artelo Biosciences Inc
2023/06/28	21:30	GlobeNewswire Inc.	Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium	NASDAQ:ARTL	Artelo Biosciences Inc

검색 관련기사 보기:NASDAQ:ARTL

1 2 3 4 5 6 7 다음 >>

Deutsche Telekom (QX)

Gold vs US Dollar

American Express

US Dollar vs Sterling

Verizon Communications

Invesco QQQ Trust Series 1

Health Care Select Sector

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관